High-Risk Ewing Sarcoma: It Is Time to Break the Ceiling

Affiliations

¹ Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, MA.
² Department of Paediatrics, Hospital for Sick Children and Princess Margaret Cancer Center, University of Toronto, Toronto, Canada.
³ Osteoncology, Bone and Soft Tissue Sarcomas and Innovative Therapies Unit, IRCCS Istituto Ortopedico Rizzoli and Bologna University, Bologna, Italy.

Editorial

Steven G DuBois et al. J Clin Oncol. 2022.

. 2022 Jul 20;40(21):2288-2290.

doi: 10.1200/JCO.22.00449. Epub 2022 Apr 15.

¹ Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, MA.
² Department of Paediatrics, Hospital for Sick Children and Princess Margaret Cancer Center, University of Toronto, Toronto, Canada.
³ Osteoncology, Bone and Soft Tissue Sarcomas and Innovative Therapies Unit, IRCCS Istituto Ortopedico Rizzoli and Bologna University, Bologna, Italy.

No abstract available

Comment in

Words Matter.
Benedetti DJ, Marron JM, Thomas SM, Caruso Brown AE, Pyke-Grimm KA, Johnson LM, Kodish E, Unguru Y. Benedetti DJ, et al. J Clin Oncol. 2023 Jan 20;41(3):706-707. doi: 10.1200/JCO.22.01056. Epub 2022 Sep 23. J Clin Oncol. 2023. PMID: 36150097 No abstract available.

High-Dose Treosulfan and Melphalan as Consolidation Therapy Versus Standard Therapy for High-Risk (Metastatic) Ewing Sarcoma.
Koch R, Gelderblom H, Haveman L, Brichard B, Jürgens H, Cyprova S, van den Berg H, Hassenpflug W, Raciborska A, Ek T, Baumhoer D, Egerer G, Eich HT, Renard M, Hauser P, Burdach S, Bovee J, Bonar F, Reichardt P, Kruseova J, Hardes J, Kühne T, Kessler T, Collaud S, Bernkopf M, Butterfaß-Bahloul T, Dhooge C, Bauer S, Kiss J, Paulussen M, Hong A, Ranft A, Timmermann B, Rascon J, Vieth V, Kanerva J, Faldum A, Metzler M, Hartmann W, Hjorth L, Bhadri V, Dirksen U. Koch R, et al. J Clin Oncol. 2022 Jul 20;40(21):2307-2320. doi: 10.1200/JCO.21.01942. Epub 2022 Apr 15. J Clin Oncol. 2022. PMID: 35427190 Clinical Trial.